The Trump administration has released its latest unified agenda, laying out the proposed and final rules its agencies plan to ...
The inflationary rebate provisions of the Inflation Reduction Act (IRA) of 2022 require pharmaceutical manufacturers to pay money back to Medicare if they raise prices faster than the rate of ...
A clear look at the 340B program: how hospitals generate revenue from drug discounts, why it has expanded, and the growing ...
KFF Health News on MSN
Copay assistance is meant to defray patient drug costs. Some insurers keep it instead.
Drugmakers provide financial assistance to help patients afford increasingly expensive medications. But some insurers do not ...
The Food and Drug Administration’s (FDA or Agency) final rule on Additional Conditions for Nonprescription Use (ACNU) paves the way for some drugs that are currently available only with a prescription ...
§ PwC estimates $1 trillion opportunity to shift healthcare spending towards a digital-first, proactive, and personalized system[3] of care that minimizes administrative burden PHILADELPHIA, Nov. 25, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results